Searched for
MODERNA SHARES
Dow Jones hits record intraday high before closing lower, S&P 500 and Nasdaq fall - here’s why US stock market started July in redUS stock market today July 1: US markets experienced a mixed trading day as the Dow Jones briefly hit a new intraday record before retreati...- US stocks: US market ends lower as tech stocks weigh on sentimentWall Street ended lower on Friday, with AI chip stocks experiencing a significant downturn while Moderna and other healthcare companies sur...
- Women are the first caregivers in this Ebola outbreak and the most at riskEastern Congo faces a rapid Ebola outbreak. Women are primary caregivers, increasing their infection risk. Many lack protective gear, forci...
- Moderna first-quarter revenue jumps on strong overseas COVID vaccine salesModerna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...
- Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
- US Stocks: Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhangModerna shares rose 9% on Wednesday after it settled a long-running legal battle over the technology that made its COVID-19 vaccine possibl...
- Moderna says FDA will consider new flu shot after resolving public disputeThe FDA will now consider Moderna's mRNA flu vaccine application after a dispute over clinical trial design. Moderna agreed to seek full ap...
- Moderna shares up 2% as skin cancer vaccine shows sustained benefit in five-year follow-upModerna and Merck said on Tuesday their experimental personalized vaccine continued to cut the risk of death or recurrence of the most dea...
- Moderna layoffs: U.S. Pharma giant announces massive job cuts, to have less than 5,000 employees, MRNA stocks sinkModerna had said earlier this year it expects operating costs to be between $4.7 billion and $5 billion for 2027. MRNA stock, which has los...
- Moderna pulls application for COVID-flu combination shotModerna has withdrawn its application for a combination flu and COVID vaccine, awaiting efficacy data from a late-stage influenza shot tria...
- Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts sayModerna, the COVID-19 vaccine manufacturer, is poised to meet its 2023 sales target as it taps into the private market. Analysts suggest th...
- Moderna says updated COVID vaccine is effective against newer variantThe company said its shot generated an 8.7-fold increase in neutralizing antibodies in humans against BA.2.86, which is being tracked by th...
- Moderna says booster dose of its COVID-19 vaccine appears protective vs. OmicronModerna Inc said on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against the fast-spreading Omicron variant...
- Moderna finds that inventing a COVID-19 vaccine was the easy partModerna shares plummeted on Thursday after it announced it would be able to supply only 700 million to 800 million vaccine doses this year,...
- Moderna working on booster to combine COVID-19 vaccine with a flu shotFlu shots cost around $18 to $25 a dose, according to U.S. government data and competition has kept price increases in check, with producer...
- India offered 7.5 million doses of Moderna vaccine; no consensus on indemnity clause: SourcesAccording to the sources, the Indian government has put forth certain conditions for finalising the indemnity clause contract and has sent ...
- Moderna to join S&P 500, shares jump after hoursModerna shares rose 6% in extended trade after the announcement. The COVID-19 vaccine maker's stock has surged over 150% this year, elevati...
- AstraZeneca has sold its stake in Moderna for more than $1 billion: The TimesAstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vac...
- Moderna's COVID-19 vaccine clears first US FDA hurdleFDA staff said a two-dose regimen of Moderna's vaccine was highly effective in preventing confirmed cases of COVID-19. The comments were ma...
- US drugmaker reports promising early results from COVID-19 vaccine testThe Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people wh...
Load More
